Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Biosimilars Insulin industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Biocon
Merck
Eli Lilly
Mylan
Pfizer
By Type:
Insulin Glargine Basaglar
Insulin Lantus
By Application:
Type I Diabetes
Type II Diabetes
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilars Insulin Market Overview 2018-2029
-
1.1 China Biosimilars Insulin Industry Development Overview
-
1.2 China Biosimilars Insulin Industry Development History
-
1.3 China Biosimilars Insulin Industry Market Size (2018-2029)
-
1.4 China Biosimilars Insulin Market Analysis by Type from Production Side
-
1.4.1 China Biosimilars Insulin Production Volume, Production Value and Growth Rate of Insulin Glargine Basaglar (2018-2029)
-
1.4.2 China Biosimilars Insulin Production Volume, Production Value and Growth Rate of Insulin Lantus (2018-2029)
-
1.5 China Biosimilars Insulin Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilars Insulin Sales Volume, Sales Value and Growth Rate of Type I Diabetes (2018-2029)
-
1.5.2 China Biosimilars Insulin Sales Volume, Sales Value and Growth Rate of Type II Diabetes (2018-2029)
-
1.6 China Biosimilars Insulin Market Analysis by Region
-
1.6.1 North China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilars Insulin Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilars Insulin Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilars Insulin Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilars Insulin Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilars Insulin Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilars Insulin Industry Development
Chapter 3 Biosimilars InsulinIndustry Chain Analysis
-
3.1 Biosimilars Insulin Industry Chain
-
3.2 Biosimilars Insulin Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilars Insulin Market
-
3.3 Biosimilars Insulin Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilars Insulin Market
Chapter 4 China Biosimilars Insulin Market, by Type
-
4.1 China Biosimilars Insulin Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilars Insulin Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilars Insulin Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilars Insulin Production Volume and Growth Rate of Insulin Glargine Basaglar
-
4.5.2 China Biosimilars Insulin Production Volume and Growth Rate of Insulin Lantus
Chapter 5 China Biosimilars Insulin Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilars Insulin Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilars Insulin Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilars Insulin Market Size and Growth Rate of Type I Diabetes
-
5.5.2 China Biosimilars Insulin Market Size and Growth Rate of Type II Diabetes
Chapter 6 China Biosimilars Insulin Market, by Region
-
6.1 China Biosimilars Insulin Production Volume and Production Value, by Region
-
6.2 China Biosimilars Insulin Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilars Insulin Market Analysis
-
7.1 North China Biosimilars Insulin Market, by Type
-
7.2 North China Biosimilars Insulin Market, by Application
Chapter 8 Central China Biosimilars Insulin Market Analysis
-
8.1 Central China Biosimilars Insulin Market, by Type
-
8.2 Central China Biosimilars Insulin Market, by Application
Chapter 9 South China Biosimilars Insulin Market Analysis
-
9.1 South China Biosimilars Insulin Market, by Type
-
9.2 South China Biosimilars Insulin Market, by Application
Chapter 10 East China Biosimilars Insulin Market Analysis
-
10.1 East China Biosimilars Insulin Market, by Type
-
10.2 East China Biosimilars Insulin Market, by Application
Chapter 11 Northeast China Biosimilars Insulin Market Analysis
-
11.1 Northeast China Biosimilars Insulin Market, by Type
-
11.2 Northeast China Biosimilars Insulin Market, by Application
Chapter 12 Southwest China Biosimilars Insulin Market Analysis
-
12.1 Southwest China Biosimilars Insulin Market, by Type
-
12.2 Southwest China Biosimilars Insulin Market, by Application
Chapter 13 Northwest China Biosimilars Insulin Market Analysis
-
13.1 Northwest China Biosimilars Insulin Market, by Type
-
13.2 Northwest China Biosimilars Insulin Market, by Application
Chapter 14 Company Profiles
-
14.1 Biocon
-
14.1.1 Biocon Company Profile
-
14.1.2 Biocon Biosimilars Insulin Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck
-
14.2.1 Merck Company Profile
-
14.2.2 Merck Biosimilars Insulin Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Profile
-
14.3.2 Eli Lilly Biosimilars Insulin Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Mylan
-
14.4.1 Mylan Company Profile
-
14.4.2 Mylan Biosimilars Insulin Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Pfizer
-
14.5.1 Pfizer Company Profile
-
14.5.2 Pfizer Biosimilars Insulin Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilars Insulin Industry Research Conclusions
-
15.2 Biosimilars Insulin Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilars Insulin Industry Market Size (2018-2029)
-
Figure China Biosimilars Insulin Production Volume, Production Value and Growth Rate of Insulin Glargine Basaglar (2018-2029)
-
Figure China Biosimilars Insulin Production Volume, Production Value and Growth Rate of Insulin Lantus (2018-2029)
-
Figure China Biosimilars Insulin Sales Volume, Sales Value and Growth Rate of Type I Diabetes (2018-2029)
-
Figure China Biosimilars Insulin Sales Volume, Sales Value and Growth Rate of Type II Diabetes (2018-2029)
-
Figure North China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilars Insulin Market Size and Growth Rate from 2018-2029
-
Figure Biosimilars Insulin Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilars Insulin Market Share by Type in 2018
-
Figure China Biosimilars Insulin Market Share by Type in 2023
-
Figure China Biosimilars Insulin Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilars Insulin Production Volume and Growth Rate of Insulin Glargine Basaglar (2018-2023)
-
Figure China Biosimilars Insulin Production Volume and Growth Rate of Insulin Lantus (2018-2023)
-
Figure China Biosimilars Insulin Market Share by Application in 2018
-
Figure China Biosimilars Insulin Market Share by Application in 2023
-
Figure China Biosimilars Insulin Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilars Insulin Market Size and Growth Rate of Type I Diabetes (2018-2023)
-
Figure China Biosimilars Insulin Market Size and Growth Rate of Type II Diabetes (2018-2023)
-
Table China Biosimilars Insulin Production Volume by Region (2018-2023)
-
Table China Biosimilars Insulin Production Volume Share by Region (2018-2023)
-
Figure China Biosimilars Insulin Production Volume Share by Region (2018-2023)
-
Table China Biosimilars Insulin Production Value by Region (2018-2023)
-
Table China Biosimilars Insulin Production Value Share by Region (2018-2023)
-
Figure China Biosimilars Insulin Production Value Share by Region (2018-2023)
-
Table China Biosimilars Insulin Sales Volume by Region (2018-2023)
-
Table China Biosimilars Insulin Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilars Insulin Sales Volume Share by Region (2018-2023)
-
Table China Biosimilars Insulin Sales Value by Region (2018-2023)
-
Table China Biosimilars Insulin Sales Value Share by Region (2018-2023)
-
Figure China Biosimilars Insulin Sales Value Share by Region (2018-2023)
-
Table North China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table North China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table North China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table North China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table Central China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table Central China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table South China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table South China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table South China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table East China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table East China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table East China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilars Insulin Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilars Insulin Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilars Insulin Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilars Insulin Sales Volume Share by Application (2018-2023)
-
Table Biocon Company Profile
-
Table Biocon Biosimilars Insulin Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Biosimilars Insulin Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Biosimilars Insulin Revenue, Price and Gross (2018-2023)
-
Table Mylan Company Profile
-
Table Mylan Biosimilars Insulin Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Biosimilars Insulin Revenue, Price and Gross (2018-2023)
-
